CORPAY, INC. Earnings Per Share Disclosure
2025 | 2024 | 2023 | ||||
Net income attributable to Corpay | $1,069,826 | $1,003,746 | $981,890 | |||
Adjustment to redemption value of redeemable noncontrolling interest | (1,480) | — | — | |||
Net income attributable to Corpay shareholders after adjustment to redemption value of redeemable noncontrolling interest | $1,068,346 | $1,003,746 | $981,890 | |||
Denominator for basic earnings per share | 70,137 | 70,331 | 73,155 | |||
Dilutive securities | 921 | 1,517 | 1,232 | |||
Denominator for diluted earnings per share | 71,058 | 71,848 | 74,387 | |||
Basic earnings per share attributable to Corpay | $15.23 | $14.27 | $13.42 | |||
Diluted earnings per share attributable to Corpay | $15.03 | $13.97 | $13.20 |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Feb 26, 2021 | |
| 2019 | Mar 2, 2020 | |
| 2018 | Mar 1, 2019 | |
| 2017 | Mar 1, 2018 | |
| 2016 | Mar 1, 2017 | |
| 2015 | Feb 29, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.